iSpecimen Inc. Pre-Tax Income
iSpecimen Inc. (ISPC) reported Pre-Tax Income of -$1.55 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2021-11-04
- iSpecimen Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-09-30 was -$1.55M.
- iSpecimen Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-06-30 was -$1.39M.
- iSpecimen Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-09-30 was -$1.25M.
- iSpecimen Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-06-30 was -$174.24K.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month |
|---|---|---|---|
| 2021-09-30 | -$1.55M 10-Q · filed 2021-11-04 | -$2.95M derived: sum of 2 quarters · filed 2021-11-04 | -$6.91M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$1.39M 10-Q · filed 2021-08-10 | -$5.36M 10-Q · filed 2021-08-10 | |
| 2020-09-30 | -$1.25M 10-Q · filed 2021-11-04 | -$1.42M derived: sum of 2 quarters · filed 2021-11-04 | -$3.06M 10-Q · filed 2021-11-04 |
| 2020-06-30 | -$174.24K 10-Q · filed 2021-08-10 | -$1.81M 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |